miRISC inhibition causes mitotic defects and synergizes with genotoxic agents in cancers
Minsi Zhang(National Center for Climate Change Strategy and International Cooperation), Gaspare La Rocca(Memorial Sloan Kettering Cancer Center), João A. Paulo(Harvard University), Ivana Lessel(Universität Hamburg), Davor Lessel(Universität Hamburg), Andrea Ventura(Memorial Sloan Kettering Cancer Center), Kevin M. Haigis(Harvard University), Juliana I. Delgado(Motlow State Community College), Vincenzo Cavalieri, Chiara Mastroleo(Motlow State Community College), Olesja Popow(Dana-Farber Cancer Institute), Turgut Dogruluk(Motlow State Community College), Melissa A. Yao(Motlow State Community College), Davide Pradella(Motlow State Community College), Tanmay Mishra(Cornell University), Y. Cendón Flórez(Motlow State Community College), Robert Benezra(Memorial Sloan Kettering Cancer Center), Moritz Weigl(Motlow State Community College), Keith Conrad Fernandez(Motlow State Community College), Joana A. Vidigal(National Institutes of Health), Ziqi Jiao(Motlow State Community College), Carol D. Morris(Memorial Sloan Kettering Cancer Center), Mateusz M. Ozimek(Motlow State Community College), Meng-Fu Bryan Tsou(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Restoration of p53 function leads to tumour regression in vivo
|Nature|2007|1.8k
Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins.
|Genes & Development|1992|472
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
|Cell Systems|2018|452
Centriole distal appendages promote membrane docking, leading to cilia initiation
|Genes & Development|2013|427